A phase I clinical study of inhaled nitric oxide in healthy adults.
暂无分享,去创建一个
Chris C. Miller | K. Kain | L. Serghides | J. Road | Y. Av‐Gay | B. McMullin | Minna K. Miller | G. Regev | Minna Miller
[1] Alison Fox-Robichaud,et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.
[2] M. Molyneux,et al. Endothelium-Based Biomarkers Are Associated with Cerebral Malaria in Malawian Children: A Retrospective Case-Control Study , 2010, PloS one.
[3] E. Gulbins,et al. Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease , 2009, Cellular microbiology.
[4] Chris C. Miller,et al. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. , 2009, Nitric oxide : biology and chemistry.
[5] M. Wolfgang,et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.
[6] Chris C. Miller,et al. Innate Protection of Mycobacterium smegmatis against the Antimicrobial Activity of Nitric Oxide Is Provided by Mycothiol , 2007, Antimicrobial Agents and Chemotherapy.
[7] C. Meisner,et al. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients , 2007, Proceedings of the National Academy of Sciences.
[8] Chris C. Miller,et al. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[9] F. Ratjen,et al. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. , 2006, American Journal of Respiratory and Critical Care Medicine.
[10] W. Hurford. Nitric oxide as a bactericidal agent: is the cure worse than the disease? , 2005, Respiratory care.
[11] Chris C. Miller,et al. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit. , 2005, Respiratory care.
[12] A. Ghahary,et al. A direct nitric oxide gas delivery system for bacterial and mammalian cell cultures. , 2005, Nitric oxide : biology and chemistry.
[13] R. Long,et al. Inhaled Nitric Oxide Treatment of Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears , 2005, Antimicrobial Agents and Chemotherapy.
[14] F. Fang. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies , 2004, Nature Reviews Microbiology.
[15] Chris C. Miller,et al. Treatment of Chronic Nonhealing Leg Ulceration with Gaseous Nitric Oxide: A Case Study , 2004, Journal of cutaneous medicine and surgery.
[16] N. Høiby,et al. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[17] C. Walsh. Opinion — anti-infectives: Where will new antibiotics come from? , 2003, Nature Reviews Microbiology.
[18] A. Harf,et al. Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearance , 2002, Critical care medicine.
[19] K. Webert,et al. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia , 2000, Critical care medicine.
[20] F. Ratjen,et al. Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. , 1999, Respiratory medicine.
[21] M. Drumm,et al. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. , 1998, The Journal of clinical investigation.
[22] M. Yacoub,et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis , 1998, The Journal of pathology.
[23] J. O’Shea. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? , 1997, Immunity.
[24] J. D. Young,et al. Kinetics of methaemoglobin and serum nitrogen oxide production during inhalation of nitric oxide in volunteers. , 1996, British journal of anaesthesia.
[25] J. D. Young,et al. Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide , 1994, Intensive Care Medicine.
[26] J. Drazen,et al. Bronchodilator action of inhaled nitric oxide in guinea pigs. , 1992, The Journal of clinical investigation.
[27] A. Meister. Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.
[28] N. Borgese,et al. Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay. , 1987, The Journal of clinical investigation.
[29] S. Tannenbaum,et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.
[30] Dundas On. INOmax ® nitric oxide for inhalation , 2014 .
[31] Chris C. Miller,et al. Infrared detection and nitric oxide treatment of bovine respiratory disease (BRD) , 2006 .
[32] C. Nathan,et al. Nitric oxide and macrophage function. , 1997, Annual review of immunology.
[33] F. Liew,et al. Nonspecific defence mechanism: the role of nitric oxide. , 1991, Immunology today.
[34] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[35] In direct , 2022 .